SPOP and prostate carcinoma: A recent study showed that PD-L1 abundance on prostate cancer cells is regulated by cyclin D. CDK4-mediated phosphorylation of SPOP and the cyclin 3-SPOP E3 ligase via proteasome-mediated degradation [125].